REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/27/2026
Back to search
Official data from USPTO
AISLE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
07/27/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
12/05/2018
Registration date
07/27/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/27/2021
Last transaction
07/27/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/02/2021
First use in commerce
02/02/2021
Drawing code
4
Owner type
03
Owner location
Oklahoma, OK, US
Examiner
WELLS, KELLEY L
Law office
M90
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Progentec Diagnostics, Inc.
Progentec Diagnostics, Inc.
Representatives
Dermot Horgan IpHorgan Ltd
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and management in the field of clinical trialspatient enrollment tracking and monitoringpharmaceutical and medicine tracking; business consulting and management in the field of clinical trialscompilation of statistics and clinical trial data for business purposes; preparing and placing advertisements for others; providing referrals of patients for enrollment in clinical trials; business consulting and management in the field of clinical trialsclinical data management; marketing consultingdesigning and developing advertising and marketing for others in relation to clinical trials and medical research; online business networking services for clinical research professionals involved in the clinical study of medical products including pharmaceuticalsbiologicsdiagnostic tools and medical devices; management and compilation of computerized databases of clinical research professionals to provide ability to contact clinical research professionals electronically including by email to evaluate clinical study protocolstake part in clinical studies and recruit patients to take part in clinical studies; promoting public awareness of the need for improved prevention and treatment of illnessesfor improved health care quality and efficiency; public advocacy to promote awareness of the need for assuring patients safe access to affordable medicine; promoting technical and scientific investigationresearchexperimentation in the field of advancement of the application of scientific discovery in connection with pharmaceuticalsdiagnostic toolsbiomarkers and medical devices; public advocacy to promote awareness of scientificresearch and medical advances; and providing an internet-based database of patient medical information designed to facilitate patient-authorizedHIPAA-compliant sharing and maintenance of patient medical information amongst a patient's doctors such that this information can be directly inserted into the doctor's medical reports as a means of increasing medical record generation efficiency and accuracy
Class 42
Medical and scientific research and development in the field of medicine; medical and scientific research in the preventiontreatmentmanagement of illness and health care delivery; medical and scientific research in the field of illness and diagnosis; technical research in the field of pharmaceutical studies; pharmaceutical product evaluation; development of pharmaceutical toolspreparations and medicines; conducting early evaluations in the field of new pharmaceuticals; medical and scientific researchconducting clinical trials for others; chemicalbiochemicalbiological and bacteriological research and analysis; biological research; medical laboratories; scientific and technological services and research and design relating theretoscientific analysis in the fields of pharmaceutical and medical device and diagnostics development; scientific research for medical purposes; design and development of computer software; research services for medical and pharmaceutical purposes; design and development of new products and services for others; design and development of computer tracking and diagnostic tools; conducting clinical trials for others; medical laboratory services; providing information about the results of clinical trials for pharmaceutical products; electronic data storage; working on and evaluation of biomarkers and diagnostic products; providing an online network service that enables users to share data in the field of healthcare; and non-downloadable computer software provided via the Internet as an Application Service Provider ASP-hosted solution for the collectioneditingorganizingmodifyingbook markingtransmissionstorage and sharing of data and information
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/27/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/22/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/21/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
06/19/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/19/2021
IUAF
USE AMENDMENT FILED
06/09/2021
EISU
TEAS STATEMENT OF USE RECEIVED
06/09/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/09/2020
EX3G
SOU EXTENSION 3 GRANTED
12/07/2020
EXT3
SOU EXTENSION 3 FILED
12/07/2020
EEXT
SOU TEAS EXTENSION RECEIVED
12/07/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/03/2020
EX2G
SOU EXTENSION 2 GRANTED
06/01/2020
EXT2
SOU EXTENSION 2 FILED
06/01/2020
EEXT
SOU TEAS EXTENSION RECEIVED
06/01/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/16/2019
EX1G
SOU EXTENSION 1 GRANTED
11/14/2019
EXT1
SOU EXTENSION 1 FILED
11/14/2019
EEXT
SOU TEAS EXTENSION RECEIVED
11/14/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/11/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/04/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/16/2019
PUBO
PUBLISHED FOR OPPOSITION
04/16/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/27/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2019
DOCK
ASSIGNED TO EXAMINER
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/22/2018
NWAP
NEW APPLICATION ENTERED
12/08/2018
Continuous trademark protection
Get notified about every new filing that threatens AISLE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.